Urologix, Inc. (NASDAQ:ULGX)
CAPS Rating:
The Company develops, manufactures and markets non-surgical, catheter-based therapies that use a proprietary cooled microwave technology for the treatment of benign prostatic hyperplasia.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
No players have picked ULGX yet. Tell us why you think ULGX will outperform or underperform the market.
RSS Headlines
Fool UK
